Adult Patients With Bronchiectasis: A First Look at the US Bronchiectasis Research Registry
- PMID: 27889361
- PMCID: PMC6026266
- DOI: 10.1016/j.chest.2016.10.055
Adult Patients With Bronchiectasis: A First Look at the US Bronchiectasis Research Registry
Abstract
Objectives: We sought to describe the characteristics of adult patients with bronchiectasis enrolled in the US Bronchiectasis Research Registry (BRR).
Methods: The BRR is a database of patients with non-cystic-fibrosis bronchiectasis (NCFB) enrolled at 13 sites in the United States. Baseline demographic, spirometric, imaging, microbiological, and therapeutic data were entered into a central Internet-based database. Patients were subsequently analyzed by the presence of NTM.
Results: We enrolled 1,826 patients between 2008 and 2014. Patients were predominantly women (79%), white (89%), and never smokers (60%), with a mean age of 64 ± 14 years. Sixty-three percent of the patients had a history of NTM disease or NTM isolated at baseline evaluation for entry into the BRR. Patients with NTM were older, predominantly women, and had bronchiectasis diagnosed at a later age than those without NTM. Gastroesophageal reflux disease (GERD) was more common in those with NTM, whereas asthma, primary immunodeficiency, and primary ciliary dyskinesia were more common in those without NTM. Fifty-one percent of patients had spirometric evidence of airflow obstruction. Patients with NTM were more likely to have diffusely dilated airways and tree-in-bud abnormalities. Pseudomonas and Staphylococcus aureus isolates were cultured less commonly in patients with NTM. Bronchial hygiene measures were used more often in those with NTM, whereas antibiotics used for exacerbations, rotating oral antibiotics, steroid use, and inhaled bronchodilators were more commonly used in those without NTM.
Conclusions: Adult patients with bronchiectasis enrolled in the US BRR are described, with differences noted in demographic, radiographic, microbiological, and treatment variables based on stratification of the presence of NTM.
Keywords: Pseudomonas; airways; bronchiectasis; nontuberculous mycobacteria; registry.
Copyright © 2016. Published by Elsevier Inc.
Figures
Comment in
-
Bronchiectasis: An Orphan Finds a Home.Chest. 2017 May;151(5):953-954. doi: 10.1016/j.chest.2016.12.026. Chest. 2017. PMID: 28483128 No abstract available.
Similar articles
-
Nontuberculous mycobacterial (NTM) infections in bronchiectasis patients: A retrospective US registry cohort study.Pulm Pharmacol Ther. 2023 Dec;83:102260. doi: 10.1016/j.pupt.2023.102260. Epub 2023 Sep 21. Pulm Pharmacol Ther. 2023. PMID: 37741357
-
Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry.Chest. 2017 Dec;152(6):1120-1127. doi: 10.1016/j.chest.2017.04.167. Epub 2017 May 5. Chest. 2017. PMID: 28479113 Free PMC article.
-
Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry Patients.Am J Respir Crit Care Med. 2024 Jul 1;210(1):108-118. doi: 10.1164/rccm.202307-1165OC. Am J Respir Crit Care Med. 2024. PMID: 38668710
-
Growing from common ground: nontuberculous mycobacteria and bronchiectasis.Eur Respir Rev. 2024 Jul 3;33(173):240058. doi: 10.1183/16000617.0058-2024. Print 2024 Jul. Eur Respir Rev. 2024. PMID: 38960614 Free PMC article. Review.
-
Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis.Biomed Res Int. 2015;2015:197950. doi: 10.1155/2015/197950. Epub 2015 May 27. Biomed Res Int. 2015. PMID: 26106603 Free PMC article. Review.
Cited by
-
Characteristics of exacerbators in the US Bronchiectasis and NTM Research Registry: a cross-sectional study.ERJ Open Res. 2024 Nov 11;10(6):00185-2024. doi: 10.1183/23120541.00185-2024. eCollection 2024 Nov. ERJ Open Res. 2024. PMID: 39534769 Free PMC article.
-
The efficacy, safety, and related factors of bronchial artery embolization for hemoptysis: a systematic review and meta-analysis with subgroup analysis.Cardiovasc Diagn Ther. 2024 Oct 31;14(5):859-877. doi: 10.21037/cdt-24-157. Epub 2024 Oct 16. Cardiovasc Diagn Ther. 2024. PMID: 39513143 Free PMC article.
-
Multi-drug resistant Pseudomonas aeruginosa isolation is an independent risk factor for recurrent hemoptysis after bronchial artery embolization in patients with idiopathic bronchiectasis: a retrospective cohort study.Respir Res. 2024 Oct 26;25(1):385. doi: 10.1186/s12931-024-03019-2. Respir Res. 2024. PMID: 39462395 Free PMC article.
-
Epidemiology of bronchiectasis at a single center in Japan: a retrospective cohort study.BMC Pulm Med. 2024 Oct 24;24(1):531. doi: 10.1186/s12890-024-03337-7. BMC Pulm Med. 2024. PMID: 39448945 Free PMC article.
-
Comparative analysis of non-tuberculous mycobacterial lung disease and lung colonization: a case-control study.BMC Infect Dis. 2024 Oct 15;24(1):1159. doi: 10.1186/s12879-024-10067-y. BMC Infect Dis. 2024. PMID: 39407161 Free PMC article.
References
-
- Metersky M.L. The initial evaluation of adults with bronchiectasis. Clin Chest. Med. 2012;33:219–231. - PubMed
-
- McShane P.J., Naureckas E.T., Tino G. Non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2013;188:647–656. - PubMed
-
- McShane P.J., Naureckas E.T., Strek M.E. Bronchiectasis in a diverse US population: effects of ethnicity on etiology and sputum culture. Chest. 2012;142:159–167. - PubMed
-
- O'Donnell A.E. Bronchiectasis. Chest. 2008;134:815–823. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
